| Deborah A Stamper, MSN | |
|
5515 W 38th St, Indianapolis, IN 46254-2919 | |
| (317) 880-3838 | |
| (317) 880-0081 |
| Full Name | Deborah A Stamper |
|---|---|
| Gender | Female |
| Speciality | Certified Clinical Nurse Specialist (cns) |
| Experience | 24 Years |
| Location | 5515 W 38th St, Indianapolis, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437161387 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Health And Hospital Corporation Of Marion County | 6709795974 | 207 |
News Archive
Regulators are clearing the runway for drones to transport vaccines and other live-saving drugs, in a ground-breaking venture funded by government.
The Senate on Monday began debate on a bill (S 1082) that would reauthorize the Prescription Drug User Fee Act, which will expire on Sept. 30, with senators expected to propose a number of amendments to the legislation, the AP/Dallas Morning News reports ( AP/Dallas Morning News , 4/30).
St. Luke's Emergency and Transport Services has received the American Heart Association's Mission: Lifeline® EMS Silver Award for implementing quality improvement measures for the treatment of patients who experience severe heart attacks.
Sanofi-aventis announced today the commencement of a tender offer through its wholly-owned subsidiary, River Acquisition Corp., for all outstanding shares of common stock of Chattem, Inc. for $93.50 per share, net to the seller in cash, without interest and less any required withholding taxes. The tender offer is being made pursuant to an Offer to Purchase, dated January 11, 2010, and in connection with the previously announced Agreement and Plan of Merger, dated December 20, 2009, among sanofi-aventis, River Acquisition Corp. and Chattem, Inc.
Merck Canada Inc. announced today that KEYTRUDATM (pembrolizumab) was authorized for sale with conditions by Health Canada on May 19, 2015. KEYTRUDA is a humanized monoclonal antibody that works by increasing the ability of the body's immune system to fight advanced melanoma, the most serious form of skin cancer. It is the first of a new class of therapies called anti-PD-1s approved in Canada.
› Verified 7 days ago
| Entity Name | Eskenazi Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730451063 PECOS PAC ID: 4284546813 Enrollment ID: O20031103000440 |
News Archive
Regulators are clearing the runway for drones to transport vaccines and other live-saving drugs, in a ground-breaking venture funded by government.
The Senate on Monday began debate on a bill (S 1082) that would reauthorize the Prescription Drug User Fee Act, which will expire on Sept. 30, with senators expected to propose a number of amendments to the legislation, the AP/Dallas Morning News reports ( AP/Dallas Morning News , 4/30).
St. Luke's Emergency and Transport Services has received the American Heart Association's Mission: Lifeline® EMS Silver Award for implementing quality improvement measures for the treatment of patients who experience severe heart attacks.
Sanofi-aventis announced today the commencement of a tender offer through its wholly-owned subsidiary, River Acquisition Corp., for all outstanding shares of common stock of Chattem, Inc. for $93.50 per share, net to the seller in cash, without interest and less any required withholding taxes. The tender offer is being made pursuant to an Offer to Purchase, dated January 11, 2010, and in connection with the previously announced Agreement and Plan of Merger, dated December 20, 2009, among sanofi-aventis, River Acquisition Corp. and Chattem, Inc.
Merck Canada Inc. announced today that KEYTRUDATM (pembrolizumab) was authorized for sale with conditions by Health Canada on May 19, 2015. KEYTRUDA is a humanized monoclonal antibody that works by increasing the ability of the body's immune system to fight advanced melanoma, the most serious form of skin cancer. It is the first of a new class of therapies called anti-PD-1s approved in Canada.
› Verified 7 days ago
| Entity Name | The Health And Hospital Corporation Of Marion County |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104027879 PECOS PAC ID: 6709795974 Enrollment ID: O20041229000426 |
News Archive
Regulators are clearing the runway for drones to transport vaccines and other live-saving drugs, in a ground-breaking venture funded by government.
The Senate on Monday began debate on a bill (S 1082) that would reauthorize the Prescription Drug User Fee Act, which will expire on Sept. 30, with senators expected to propose a number of amendments to the legislation, the AP/Dallas Morning News reports ( AP/Dallas Morning News , 4/30).
St. Luke's Emergency and Transport Services has received the American Heart Association's Mission: Lifeline® EMS Silver Award for implementing quality improvement measures for the treatment of patients who experience severe heart attacks.
Sanofi-aventis announced today the commencement of a tender offer through its wholly-owned subsidiary, River Acquisition Corp., for all outstanding shares of common stock of Chattem, Inc. for $93.50 per share, net to the seller in cash, without interest and less any required withholding taxes. The tender offer is being made pursuant to an Offer to Purchase, dated January 11, 2010, and in connection with the previously announced Agreement and Plan of Merger, dated December 20, 2009, among sanofi-aventis, River Acquisition Corp. and Chattem, Inc.
Merck Canada Inc. announced today that KEYTRUDATM (pembrolizumab) was authorized for sale with conditions by Health Canada on May 19, 2015. KEYTRUDA is a humanized monoclonal antibody that works by increasing the ability of the body's immune system to fight advanced melanoma, the most serious form of skin cancer. It is the first of a new class of therapies called anti-PD-1s approved in Canada.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Deborah A Stamper, MSN 13800 E Base Rd, Columbus, IN 47203-9652 Ph: (812) 579-6781 | Deborah A Stamper, MSN 5515 W 38th St, Indianapolis, IN 46254-2919 Ph: (317) 880-3838 |
News Archive
Regulators are clearing the runway for drones to transport vaccines and other live-saving drugs, in a ground-breaking venture funded by government.
The Senate on Monday began debate on a bill (S 1082) that would reauthorize the Prescription Drug User Fee Act, which will expire on Sept. 30, with senators expected to propose a number of amendments to the legislation, the AP/Dallas Morning News reports ( AP/Dallas Morning News , 4/30).
St. Luke's Emergency and Transport Services has received the American Heart Association's Mission: Lifeline® EMS Silver Award for implementing quality improvement measures for the treatment of patients who experience severe heart attacks.
Sanofi-aventis announced today the commencement of a tender offer through its wholly-owned subsidiary, River Acquisition Corp., for all outstanding shares of common stock of Chattem, Inc. for $93.50 per share, net to the seller in cash, without interest and less any required withholding taxes. The tender offer is being made pursuant to an Offer to Purchase, dated January 11, 2010, and in connection with the previously announced Agreement and Plan of Merger, dated December 20, 2009, among sanofi-aventis, River Acquisition Corp. and Chattem, Inc.
Merck Canada Inc. announced today that KEYTRUDATM (pembrolizumab) was authorized for sale with conditions by Health Canada on May 19, 2015. KEYTRUDA is a humanized monoclonal antibody that works by increasing the ability of the body's immune system to fight advanced melanoma, the most serious form of skin cancer. It is the first of a new class of therapies called anti-PD-1s approved in Canada.
› Verified 7 days ago
Ms. Monica Silvia Oclander, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Action Health Center, 2868 N. Pennsylvania Street, Indianapolis, IN 46205 Phone: 317-221-3532 Fax: 317-221-3516 | |
Tia Imhoff Mcgee, FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 705 Riley Hospital Dr, Indianapolis, IN 46202 Phone: 317-312-2204 | |
Kathleen L Lampert, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1550 E County Line Rd, Ste 300, Indianapolis, IN 46227 Phone: 317-497-2300 | |
Mrs. Yvette Monique Caviness-kelley, FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 5629 Lee Rd, Indianapolis, IN 46216 Phone: 317-419-6800 | |
Mrs. Renee Marie Burkhart, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 7825 Mcfarland Ln, Suite A, Indianapolis, IN 46237 Phone: 317-887-5500 Fax: 317-887-4806 | |
Emily Kelly Koffel, AGACNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 8330 Naab Rd Ste 340, Indianapolis, IN 46260 Phone: 317-338-5100 | |
Mrs. Kelly Lentz, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2732 W Michigan St, Indianapolis, IN 46222 Phone: 317-554-4600 Fax: 317-554-4617 |